Loading company…
Seagen Inc., formerly Seattle Genetics, is a Bothell, Washington biotechnology company developing antibody-based cancer therapies.
Founded in 1998 and based in Washington, US, Seagen Inc., formerly known as Seattle Genetics, Inc., develops antibody-based therapies for the treatment of cancer. The company's stage is listed as Public.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in